Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19054556 | Variable Flow Control Device, System, and Method | February 2025 | July 2025 | Allow | 5 | 2 | 0 | Yes | No |
| 19101262 | LUNG TREATMENT | February 2025 | June 2025 | Allow | 4 | 0 | 0 | No | No |
| 19025395 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 19025482 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 19025342 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 19025323 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 19025432 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 19025373 | AUTOINJECTOR | January 2025 | August 2025 | Allow | 7 | 2 | 0 | No | No |
| 18999393 | METHOD OF TREATING A BLOOD VESSEL IN A SUBJECT | December 2024 | August 2025 | Allow | 7 | 1 | 0 | No | No |
| 18823628 | PAIN TREATMENT USING WANDING OF PERCUTANEOUS SURGICAL PROBE OVER SENSORY NERVE | September 2024 | December 2024 | Allow | 3 | 0 | 0 | No | No |
| 18839081 | AN ENEMA NOZZLE COMPRISING RETENTION MEANS, AND AN ENEMA SYSTEM COMPRISING SAID ENEMA NOZZLE | August 2024 | January 2025 | Allow | 5 | 0 | 0 | No | No |
| 18760216 | Medicament Delivery Device with Use Indicator | July 2024 | January 2025 | Allow | 7 | 1 | 0 | No | No |
| 18760477 | Medicament Delivery Device with Use Indicator | July 2024 | January 2025 | Allow | 7 | 1 | 0 | No | No |
| 18760391 | Medicament Delivery Device with Use Indicator | July 2024 | January 2025 | Allow | 7 | 1 | 0 | No | No |
| 18608719 | PROCESS FOR RESPIRATORY REHABILITATION TREATMENT | March 2024 | September 2025 | Allow | 18 | 3 | 0 | Yes | No |
| 18581809 | FLUID STIMULATION METHODS AND DEVICES FOR TREATING FLUID OVERLOAD | February 2024 | June 2024 | Allow | 4 | 0 | 0 | No | No |
| 18440996 | NASAL CATHETER WITH GUIDE WALL | February 2024 | May 2024 | Allow | 3 | 1 | 0 | No | No |
| 18383582 | METHODS AND TECHNIQUES FOR TREATING FACIAL ASSYMETRY BY ADMINISTERING DERMAL INJECTIONS TO PATIENTS BASED UPON GESTATIONAL PATTERNS | October 2023 | May 2024 | Allow | 6 | 0 | 0 | No | No |
| 18488571 | ELECTROCAUTERY RHIZOTOMY USING WANDING OF ENERGIZED ELECTROCAUTERY PROBE | October 2023 | February 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18469376 | SYSTEMS, DEVICES, AND METHODS FOR ACCESSING A SUBDURAL SPACE | September 2023 | May 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18275919 | A Dose Counting System | August 2023 | February 2026 | Allow | 31 | 0 | 0 | No | No |
| 18230168 | SKIN CARE DEVICE WITH PLASMA GENERATING DEVICE | August 2023 | January 2024 | Allow | 6 | 1 | 0 | No | No |
| 18350412 | Fluid-Management System and Method | July 2023 | February 2026 | Allow | 32 | 0 | 0 | No | No |
| 18208099 | SYSTEMS, DEVICES, AND METHOD FOR TREATING A SINUS CONDITION | June 2023 | October 2025 | Allow | 28 | 1 | 0 | No | No |
| 18328231 | PATIENT-CONTROLLED LIQUID ORAL MEDICINE DISPENSER AND DEACTIVATION SYSTEM | June 2023 | August 2023 | Allow | 2 | 0 | 0 | Yes | No |
| 18327752 | INFUSION DEVICES AND RELATED MEAL BOLUS ADJUSTMENT METHODS | June 2023 | November 2025 | Allow | 29 | 0 | 0 | No | No |
| 18255226 | INTERSTITIAL PHOTODYNAMIC THERAPY PROBE DELIVERY DEVICE | May 2023 | August 2023 | Allow | 3 | 0 | 0 | No | No |
| 18254674 | MEDICAL GAS DUCTS FOR MEDICAL GAS EVACUATION DEVICES AND RELATED SYSTEMS AND METHODS | May 2023 | March 2026 | Allow | 34 | 0 | 0 | Yes | No |
| 18200520 | APPARATUS AND METHOD FOR INACTIVATING INFECTIOUS ORGANISMS IN HUMAN BODY | May 2023 | October 2025 | Allow | 29 | 1 | 0 | No | No |
| 18199105 | Anchoring a Medical Instrument | May 2023 | June 2025 | Allow | 24 | 1 | 0 | No | No |
| 18310881 | AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAME | May 2023 | April 2025 | Allow | 24 | 0 | 0 | No | No |
| 18141343 | DEVICE AND METHOD FOR TRAINING USERS OF AMBULATORY MEDICAL DEVICES | April 2023 | July 2025 | Allow | 27 | 1 | 0 | No | No |
| 18304174 | SAFE CORRECTION BOLUSES | April 2023 | August 2025 | Allow | 28 | 1 | 0 | No | No |
| 18135383 | Trocar Support | April 2023 | November 2025 | Allow | 31 | 2 | 0 | Yes | No |
| 18190450 | METHOD TO SECURE AN ELASTIC COMPONENT IN A VALVE | March 2023 | November 2025 | Abandon | 32 | 1 | 0 | No | No |
| 18124989 | Cryogenic Enhancement of Joint Function, Alleviation of Joint Stiffness and/or Alleviation of Pain Associated With Osteoarthritis | March 2023 | July 2025 | Allow | 27 | 1 | 0 | No | No |
| 18188373 | PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS | March 2023 | October 2025 | Allow | 31 | 1 | 0 | No | No |
| 18121515 | HANDLE DEVICE FOR PROVIDING OXYGEN AT THE HEAD OF A SKIN CARE DEVICE | March 2023 | October 2023 | Allow | 7 | 1 | 0 | No | No |
| 18117015 | SHEATH ASSEMBLY FOR INSERTION OF A CORD-SHAPED ELEMENT, PARTICULARLY A CATHETER, INTO THE BODY OF A PATIENT | March 2023 | June 2025 | Allow | 28 | 1 | 0 | No | No |
| 18177958 | Image Guided Surgery System Guide Wire and Methods of Manufacturing and Use | March 2023 | June 2025 | Allow | 28 | 1 | 1 | No | No |
| 18114709 | Methods And Apparatus For Disinfecting And Reflux Prevention Flush Syringe Assembly | February 2023 | September 2025 | Allow | 30 | 2 | 0 | No | No |
| 18174962 | AUGMENTED DELIVERY CATHETER AND METHOD | February 2023 | June 2025 | Allow | 28 | 1 | 0 | No | No |
| 18110615 | INTRODUCER SHEATH ASSEMBLY HAVING A LOCKING DILATOR | February 2023 | September 2025 | Allow | 31 | 0 | 0 | No | No |
| 18170456 | SYSTEMS AND METHODS FOR SELECTIVELY OCCLUDING THE SUPERIOR VENA CAVA FOR TREATING HEART CONDITIONS | February 2023 | March 2025 | Allow | 25 | 0 | 1 | No | No |
| 18169774 | PREFILLED SYRINGE WITH BREAKAWAY FORCE FEATURE | February 2023 | May 2025 | Allow | 27 | 1 | 0 | No | No |
| 18108124 | Fluid-Management System and Method | February 2023 | May 2023 | Allow | 3 | 0 | 0 | No | No |
| 18104507 | INDWELLING LUMINAL DEVICES | February 2023 | May 2025 | Allow | 27 | 1 | 0 | No | No |
| 18103773 | Fluid-Management System and Method | January 2023 | July 2023 | Allow | 5 | 1 | 0 | No | No |
| 18095225 | FLUID STIMULATION METHODS AND DEVICES FOR TREATING FLUID OVERLOAD | January 2023 | September 2023 | Allow | 8 | 1 | 0 | No | No |
| 18003870 | MULTI-LAYER MICRONEEDLE STRUCTURE AND METHOD FOR MANUFACTURING SAME | December 2022 | March 2026 | Allow | 38 | 1 | 0 | No | No |
| 18003379 | CATHETER FIXATION DEVICE | December 2022 | February 2026 | Allow | 38 | 1 | 0 | No | No |
| 18087993 | MULTI-USE BLOOD CONTROL SAFETY CATHETER ASSEMBLY | December 2022 | February 2026 | Allow | 37 | 2 | 1 | No | No |
| 18083175 | AUTOMATIC INJECTOR WITH NEEDLE COVER | December 2022 | May 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18066328 | MAGNETIC CONTROL OF FLUID IN A FLUID MANAGEMENT SYSTEM | December 2022 | March 2026 | Allow | 39 | 1 | 0 | No | No |
| 18065078 | REAL-TIME SAMPLING DEVICE | December 2022 | November 2024 | Allow | 23 | 0 | 0 | No | No |
| 18063693 | SAFETY INJECTOR | December 2022 | November 2025 | Allow | 35 | 1 | 0 | No | No |
| 18071932 | APPARATUS AND METHODS FOR RESTORING TISSUE | November 2022 | July 2025 | Abandon | 31 | 1 | 0 | No | No |
| 18072193 | CATHETER DELIVERY DEVICE AND RELATED SYSTEMS AND METHODS | November 2022 | August 2025 | Allow | 32 | 2 | 0 | Yes | No |
| 17991984 | INTRACRANIAL ABNORMALITY REMOVAL SYSTEM | November 2022 | March 2024 | Abandon | 16 | 2 | 0 | No | No |
| 18057411 | INTEGRATED NEEDLE-CATHETER SYSTEMS AND METHODS OF USE | November 2022 | March 2026 | Allow | 40 | 2 | 1 | No | No |
| 17924803 | Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug | November 2022 | January 2026 | Allow | 38 | 1 | 0 | No | No |
| 17977592 | PRECISION ROLLER CLAMP ASSEMBLY | October 2022 | October 2024 | Allow | 24 | 0 | 0 | No | No |
| 17997548 | DOSE CAPTURE ADD-ON DEVICE FOR HANDHELD INJECTION SYRINGE | October 2022 | January 2026 | Allow | 39 | 1 | 0 | No | No |
| 17996968 | CLOSED-LOOP DRUG INFUSION SYSTEM WITH SYNERGIC CONTROL | October 2022 | February 2026 | Allow | 40 | 1 | 0 | No | No |
| 17968165 | SYSTEMS AND METHODS FOR DELIVERING PRESSURIZED FLUID TO A TARGET SITE ALONE OR IN CONJUNCTION WITH THERAPEUTIC AGENTS | October 2022 | August 2025 | Allow | 34 | 0 | 0 | No | No |
| 17968294 | INFUSION LUBRICATED ATHERECTOMY CATHETER | October 2022 | February 2025 | Allow | 28 | 1 | 0 | No | No |
| 18047068 | DRIVE MECHANISM FOR POSITIVE DISPLACEMENT PUMPS | October 2022 | February 2026 | Allow | 40 | 1 | 0 | No | No |
| 17965288 | INGESTIBLE DEVICE WITH PHARMACEUTICAL PRODUCT | October 2022 | January 2026 | Abandon | 39 | 2 | 0 | No | No |
| 17964089 | PERSISTENT PERFUSION SHEATH | October 2022 | September 2024 | Allow | 23 | 0 | 0 | No | No |
| 17963633 | MEDICAL TOOL POSITIONING DEVICES, SYSTEMS, AND METHODS OF USE AND MANUFACTURE | October 2022 | November 2025 | Allow | 37 | 3 | 0 | No | No |
| 18045245 | MEDICAL CONNECTOR WITH CLOSEABLE LUER CONNECTOR | October 2022 | August 2024 | Allow | 23 | 0 | 0 | No | No |
| 17958935 | HIGH ENERGY ASSISTED DRUG DELIVERY AND VASCULAR REMODELING | October 2022 | July 2025 | Allow | 33 | 0 | 0 | No | No |
| 17951036 | ALIGNING MEDICAL INSTRUMENTS TO ACCESS ANATOMY | September 2022 | September 2024 | Allow | 24 | 0 | 0 | No | No |
| 17946674 | AUTOMATIC INJECTOR | September 2022 | April 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17941353 | PROGRAMMABLE THERAPEUTIC AGENT DELIVERY FROM EYE MOUNTED DEVICE | September 2022 | September 2024 | Allow | 24 | 0 | 0 | No | No |
| 17908593 | BALLOON CATHETER | September 2022 | September 2025 | Allow | 36 | 0 | 0 | No | No |
| 17823298 | NITRIC OXIDE-RELEASING DEVICE | August 2022 | June 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17898337 | Stabilization Device, System, and Methods Thereof for Integrated Catheters | August 2022 | November 2024 | Allow | 27 | 1 | 0 | No | No |
| 17905102 | COVER BODY AND DEVICE FOR INJECTING MEDICAL LIQUID COMPRISING SAME | August 2022 | February 2026 | Abandon | 42 | 1 | 0 | No | No |
| 17802511 | SECUREMENT ASSEMBLY AND METHOD FOR CENTRAL VENOUS ACCESS DEVICES AND SURGICAL DRAINS | August 2022 | January 2026 | Allow | 41 | 1 | 0 | No | No |
| 17893378 | Apparatus and Methods for Delivering Cold Perfusion Fluids in Organ Donors | August 2022 | September 2024 | Allow | 25 | 0 | 0 | No | No |
| 17887987 | ASSISTED ASPIRATION CATHETER SYSTEM | August 2022 | February 2025 | Allow | 30 | 1 | 0 | No | No |
| 17888208 | Multiple Wire Balloon Dilation Catheter | August 2022 | February 2023 | Allow | 6 | 0 | 0 | No | No |
| 17881751 | NASAL SUCTION INSTRUMENT WITH INTERCHANGEABLE TIP INSERT | August 2022 | January 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 17879702 | VARIABLE FLOW CONTROL DEVICE, SYSTEM AND METHOD | August 2022 | March 2025 | Allow | 31 | 1 | 1 | Yes | No |
| 17816615 | DEVICES AND METHODS FOR PRECISION DOSE DELIVERY | August 2022 | January 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 17816669 | METHOD OF SUPRA-AORTIC ACCESS FOR A NEUROVASCULAR PROCEDURE | August 2022 | October 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17874574 | ERGONOMIC IV SYSTEMS AND METHODS | July 2022 | January 2025 | Allow | 29 | 1 | 0 | No | No |
| 17872260 | VENOUS-TO-VENOUS LOCO-REGIONAL DELIVERY OF A THERAPEUTIC AGENT | July 2022 | March 2026 | Abandon | 43 | 1 | 0 | No | No |
| 17812995 | METHOD AND DEVICE FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE USING A MICROPROJECTION ARRAY | July 2022 | April 2025 | Allow | 33 | 1 | 0 | No | No |
| 17863199 | MODULAR MEDICAL DEVICES AND METHODS OF USING THE SAME | July 2022 | May 2025 | Allow | 35 | 0 | 0 | No | No |
| 17858452 | EYE MOUNTED DEVICE FOR THERAPEUTIC AGENT RELEASE | July 2022 | August 2024 | Allow | 25 | 0 | 0 | No | No |
| 17852603 | BENEFIT AGENT DELIVERY SYSTEM COMPRISING REVERSE MICELLES | June 2022 | July 2025 | Allow | 36 | 0 | 0 | No | No |
| 17851735 | BENEFIT AGENT DELIVERY SYSTEM UTILIZING AN ELECTRIC FIELD | June 2022 | October 2025 | Allow | 40 | 1 | 0 | No | No |
| 17850833 | Method and Device for Verification of Intra-Luminal Placement and Patency for Vascular Access Devices | June 2022 | October 2024 | Allow | 27 | 1 | 0 | No | No |
| 17849222 | Autoinjector | June 2022 | April 2024 | Allow | 22 | 0 | 0 | No | No |
| 17808426 | Attachment for a Device for Generating an Air Flow or Dispensing a Fluid into the External Auditory Canal | June 2022 | July 2024 | Allow | 25 | 0 | 0 | No | No |
| 17787664 | Apparatus for Detecting a Manipulation of an Injection Device | June 2022 | October 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17786883 | SELECTIVE DRUG DELIVERY IN AN ION PUMP THROUGH PROTON ENTRAPMENT | June 2022 | February 2026 | Abandon | 44 | 1 | 0 | No | No |
| 17806898 | THERAPY MANAGEMENT SYSTEMS, METHODS, AND DEVICES | June 2022 | June 2024 | Allow | 25 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HALL, DEANNA K.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner HALL, DEANNA K works in Art Unit 3783 and has examined 525 patent applications in our dataset. With an allowance rate of 85.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.
Examiner HALL, DEANNA K's allowance rate of 85.9% places them in the 63% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by HALL, DEANNA K receive 1.50 office actions before reaching final disposition. This places the examiner in the 26% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by HALL, DEANNA K is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a -0.4% benefit to allowance rate for applications examined by HALL, DEANNA K. This interview benefit is in the 12% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 33.6% of applications are subsequently allowed. This success rate is in the 73% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 30.8% of cases where such amendments are filed. This entry rate is in the 45% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 81.8% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 43.9% are granted (fully or in part). This grant rate is in the 37% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.9% of allowed cases (in the 80% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.